MEDI logo

Medistim Stock Price

Symbol: OB:MEDIMarket Cap: NOK 4.3bCategory: Healthcare

MEDI Share Price Performance

NOK 232.00
69.00 (42.33%)
10.8% undervalued intrinsic discount
NOK 260.00
Fair Value
NOK 232.00
69.00 (42.33%)
10.8% undervalued intrinsic discount
NOK 260.00
Fair Value
Price NOK 232.00
AnalystHighTarget NOK 260.00
AnalystConsensusTarget NOK 225.00

MEDI Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value NOK 260.00 10.8% undervalued intrinsic discount

Healthcare Digitization And Aging Will Boost Intraoperative Imaging Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value NOK 225.00 3.1% overvalued intrinsic discount

R&D Investments May Impact Margins, But New Products Could Boost Future Revenue

1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent MEDI News & Updates

No updates

Medistim ASA Key Details

NOK 603.9m

Revenue

NOK 119.3m

Cost of Revenue

NOK 484.7m

Gross Profit

NOK 361.8m

Other Expenses

NOK 122.9m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 20, 2025
Earnings per share (EPS)
6.73
Gross Margin
80.25%
Net Profit Margin
20.35%
Debt/Equity Ratio
0%

Medistim ASA Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About MEDI

Founded
1984
Employees
154
CEO
Kari Krogstad
WebsiteView website
www.medistim.com

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Norwegian Market Performance

  • 7 Days: -0.6%
  • 3 Months: 6.6%
  • 1 Year: 10.5%
  • Year to Date: 5.7%
The market has been flat over the last week. As for the longer term, the market has risen 11% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading